Intravitreal Delivery of PEGylated-ECO Plasmid DNA Nanoparticles for Gene Therapy of Stargardt Disease
ConclusionsIntravitreal delivery of the PEG-ELNP ofpGRK1-ABCA4-S/MAR is a promising approach for gene therapy of Stargardt Disease, which can also be a delivery platform for gene therapy of other inherited retinal diseases.
Source: Pharmaceutical Research - Category: Drugs & Pharmacology Source Type: research
More News: Drugs & Pharmacology | Eyes | Gene Therapy | Genetics | Nanotechnology | Ophthalmoscopy | Opthalmology | PET Scan | Vitamin A